Brian C. Beard, PhD

AVP, CMC-Lentivirus & AAV

Brian brings over 15 years’ experience working on cell and gene therapies. Prior to joining Rocket, he was a faculty member in the Clinical Research Division at Fred Hutchinson Cancer Research Center and the Department of Medicine at University of Washington. Brian was responsible for gene-modified cell manufacturing, project management, process and analytics development, and translating pre-clinical protocols to clinical protocols, which led to implementation of three hematopoietic stem cell (HSC) gene therapy FDA approved INDs. He was also the supervisor of the Core Center of Excellence in Hematology (CCEH) Virus Vector Production and the lead of clinical GMP lentivirus production process development.

Brian has a PhD in Biochemistry from Washington State University. Brian has dedicated both his professional and personal life to advancing curative therapies to patient populations in need.

Back to Management